Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0707 per EA under NDC 33342033511. Its NADAC has been published 125 times since Apr 3, 2024.
FDA first approved this application on May 24, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342033511
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA209827FDA Approved
5/24/2023
TE Code
AB
On Market Since
5/24/2023
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 125 times since Apr 3, 2024, and over the history we have for it it has declined 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0707 per EA |
|---|---|
| All-time high | $0.0919 (Apr 10, 2024) |
| All-time low | $0.0661 (Nov 20, 2024) |
| 52-week high | $0.0864 |
| 52-week low | $0.0707 |
| Median price | $0.0759 |
| Average price | $0.0766 |
| Largest weekly change | -23.5% (Jul 17, 2024) |
| Weeks tracked | 125 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0707 per EA (NDC 33342033511), effective Aug 19, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has declined 23.0%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Apr 3, 2024, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0661 (Nov 20, 2024) to a high of $0.0919 (Apr 10, 2024), with a median of $0.0759 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 33342033511) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.